Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
p53-DC Vaccine and Aromatase Inhibitor in Breast Cancer
NCT00935558Phase 2Withdrawn
- Start
- Jul 2009
- Primary completion
- May 2012
- Countries
- 1
01
Overview
A Phase 2 trial of mutant p53 peptide pulsed dendritic cell vaccine in breast cancer. Planned start Jul 2009; status: withdrawn.
02
Drugs
mutant p53 peptide pulsed dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00935558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935558.